Corbus Pharmaceuticals Holdings, Inc.
CRBP
$7.70
$0.141.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.97M | -20.56M | -23.34M | -17.66M | -16.98M |
| Total Depreciation and Amortization | 49.00K | 49.00K | 50.00K | 53.00K | 81.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.65M | 750.00K | 1.58M | 888.00K | 1.48M |
| Change in Net Operating Assets | -4.31M | 3.84M | 6.16M | 122.00K | -1.00M |
| Cash from Operations | -25.57M | -15.92M | -15.55M | -16.60M | -16.42M |
| Capital Expenditure | -6.00K | -7.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.46M | -57.14M | 19.64M | 17.74M | 18.12M |
| Cash from Investing | 22.46M | -57.15M | 19.64M | 17.74M | 18.12M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 74.58M | 2.85M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 74.58M | 2.85M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.12M | 1.51M | 6.94M | 1.14M | 1.70M |